CTKB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cytek Biosciences Inc

Watchlist Manager

Watchlist

Price: 4.46 USD 1.13% Market Closed

Market Cap: $576m

	Cytek Biosciences Inc NASDAQ:CTKB	US
F	F5 Inc XETRA:FFV	US
C	Conagra Brands Inc XBER:CAO	US
	Merus Power Oyj F:99H	FI
A	Acen Corp XPHS:ACEN	PH
T	Takkt AG XMUN:TTK	DE
T	Takashimaya Co Ltd XMUN:TKM	JP
A	Aptargroup Inc XBER:AGT	US
	Intact Financial Corp TSX:IFC	CA

Profitability Summary

Cytek Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

52%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

60% > 52%

Negative Operating Margin

-21%

Negative 3Y Average Operating Margin

-14%

Declining Operating Margin

-11% > -21%

Negative Net Margin

-36%

Negative 3Y Average Net Margin

-10%

Declining Net Margin

-3% > -36%

Negative Free Cash Flow Margin

-6%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

-6% > -6%

Negative ROE

-21%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-17%

Declining ROIC

-7% > -46%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

52%

Strong 3Y Average Gross Margin

55%

Declining Gross Margin

60% > 52%

Negative Operating Margin

-21%

Negative 3Y Average Operating Margin

-14%

Declining Operating Margin

-11% > -21%